Related Experiment Video
Updated: Jul 19, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Unexplained Nausea and Vomiting
Koch1
1Department of Medicine/Gastroenterology Division, The Milton S. Hershey Medical Center, PO Box 850, Hershey, PA 17033-0850, USA. Kkoch@psu.edu
Current Treatment Options in Gastroenterology
|November 30, 2000
Summary
Nausea and vomiting can stem from gastric neuromuscular disorders when common gastrointestinal issues are ruled out. Effective management involves patient education and targeted therapies for motility dysfunction.
Area of Science:
- Gastroenterology
- Neurogastroenterology
- Internal Medicine
Background:
- Nausea and vomiting are common, debilitating symptoms posing diagnostic and management challenges.
- Specific diagnoses are crucial; therapy targeting the underlying lesion often resolves symptoms.
- When standard gastrointestinal causes are excluded, gastric neuromuscular disorders become primary considerations.
Purpose of the Study:
- To outline the diagnostic considerations for nausea and vomiting.
- To explore gastric neuromuscular disorders as a cause of these symptoms.
- To detail treatment strategies for nausea and vomiting stemming from gastric motility dysfunction.
Main Methods:
- Review of pathophysiological causes of nausea and vomiting.
- Identification of gastric neuromuscular disorders, including dysrhythmias, accommodation abnormalities, and gastroparesis.
- Compilation of treatment modalities for nausea and vomiting related to gastric neuromuscular dysfunction.
Main Results:
- Gastric neuromuscular disorders encompass a spectrum of motility abnormalities.
- Treatment options range from conservative measures to advanced interventions.
- Successful management hinges on understanding pathophysiology and patient education.
Conclusions:
- Gastric neuromuscular dysfunction is a significant cause of unexplained nausea and vomiting.
- A multi-faceted treatment approach, including patient education and specific therapies, is essential.
- Addressing the pathophysiology of motility disorders improves patient outcomes.
Related Concept Videos
01:15Equilibrium and Balance
The inner ear assumes dual functionalities of auditory perception and equilibrium maintenance. The vestibule is the organ responsible for balance. This organ contains mechanoreceptors, specifically hair cells, endowed with stereocilia, which aid in deciphering information regarding the position and motion of our heads. Two intrinsic components, the utricle and saccule, help perceive head position, while the semicircular canals track head movement. Neurological messages initiated in the...
01:22Pathophysiology of Vomiting
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through interaction...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
01:23Gastritis III: Clinical Manifestations and Management
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:11Pyloric Obstruction
Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...